Age-related macular degeneration is the leading cause of loss of sight in those over the age of 60 years. Various treatment options are available
Age-related macular degeneration is associated with release of growth factors including vascular endothelial growth factor (VEGF) which causes blood vessels in the eye to leak and also produce new vessels called macular neovascularisation which can cause a bleed inside the central part of the eye.
Anti-VEGF injections will block the VEGF growth factor and improve the leakage of fluid and prevent further complications such as bleeding inside the eye.
The aim of intravitreal anti-VEGF injections is to stabilise vision in 90-95% of patients with a 30% chance of improving vision by 2 lines on the vision chart or 10 letters on the ETDRS vision chart. Without treatment, there is 1:2 chance of vision remaining the same without getting worse.
The risks for intravitreal injections include 1:3000 chance of severe visual loss, seeing floaters for a few days, mild redness, grittiness and discomfort.
Our Consultants at VISIO Health have the expertise in treating age-related macular degeneration and will help you decide in which treatment option is best for you.
Avastin eye injection | £750 |
Lucentis eye injection | £1,700 |
Eylea eye injection | £1,800 |
Vabysmo eye injection | £1,950 |
Diabetic macular oedema results in leak of fluid in the central part of the eye called the macula. This occurs due to changes in the eye after a few years of having diabetes and is called diabetic retinopathy. Diabetic eye disease (Retinopathy). The macula is a vital part of the retina or the central part of the back of the eye that helps you to read, see colour and define detail. The leak of fluid results in macular oedema causing loss of vision or difficulty in reading. There is also a lack of oxygen in the surrounding areas of the retina which can also affect the vision. This is associated with release of growth factors including vascular endothelial growth factor (VEGF) which causes blood vessels in the eye to leak and also produce new vessels called neovascularisation which can cause bleeds inside the eye.
Intravitreal injections are usually indicated when there is development of macular oedema.
Anti-VEGF injections will block the VEGF growth and improve the leakage of fluid and prevent further complications such as bleeding inside the eye.
Steroid eye injections improve the leakage of fluid by counteracting inflammatory pathways. A steroid implant is an effective way to deliver steroid inside the eye by injecting an implant which can last in the eye by releasing a small amount of steroid slowly over a period of 4-6 months for up to 3 years.
Various options that are available for the treatment of macular oedema will improve vision in 30-60% of patients depending on the type of injection used and the severity of the eye condition.
The risks for intravitreal injections include 1:3000 chance of severe visual loss, seeing floaters for a few days, mild redness, grittiness and discomfort. Steroid injections also carry of risk for development of a cataract and infrequently a rise in intraocular or eye pressure which can usually be managed with eyedrops.
Our Consultants at VISIO Health have the expertise in treating diabetic macular oedema and will help you decide in which treatment option is best for you.
Avastin eye injection | £750 |
Lucentis eye injection | £1,700 |
Eylea eye injection | £1,800 |
Vabysmo eye injection | £1,950 |
Triamcinolone or Intracinol eye injections | £750 |
Ozurdex eye injection | £2,800 |
Iluvien eye injection x 1 (lasts 36 months) | £8,500 |
Retinal vein occlusion results in leaking out of the blood and protein into the retina due to blockage of the retinal vein leading to fluid collection in the retina causing a retinal swelling which is also known as macular oedema.
There is also a lack of oxygen in the surrounding areas of the retina which can also affect the vision. This is associated with release of growth factors including vascular endothelial growth factor (VEGF) which causes blood vessels in the eye to leak and also produce new vessels called neovascularisation which can cause bleed inside the eye.
Intravitreal injections are usually indicated when there is development of macular oedema.
Anti-VEGF injections will block the VEGF growth and improve the leakage of fluid and prevent further complications such as bleeding inside the eye.
Steroid eye injections improve the leakage of fluid by counteracting inflammatory pathways. A steroid implant is an effective way to deliver steroid inside the eye by injecting an implant which can last in the eye by releasing a small amount of steroid slowly over a period of 4-6 months for up to 3 years.
Various options that are available for the treatment of macular oedema will improve vision in 30-60% of patients depending on the type of injection used and the severity of the eye condition.
The risks for intravitreal injections include 1:3000 chance of severe visual loss, seeing floaters for a few days, mild redness, grittiness and discomfort. Steroid injections also carry of risk for development of a cataract and infrequently a rise in intraocular or eye pressure which can usually be managed with eyedrops.
Our Consultants at VISIO Health have the expertise in treating retinal vein occlusion and will help you decide in which treatment option is best for you.
Avastin eye injection | £750 |
Triamcinolone or Intracinol eye injections | £750 |
Lucentis eye injection | £1,700 |
Eylea eye injection | £1,800 |
Vabysmo eye injection | £1,950 |
Triamcinolone or Intracinol eye injections | £750 |
Ozurdex eye injection | £2,800 |
Intravitreal injections into the eye are usually administered if the uveitis is limited to one eye. Occasionally, bilateral or injections in both eyes may be advised depending on the type of uveitis
Various options are available for the treatment of uveitis including injection of steroid implant into the eye. Steroid eye injections improve the leakage of fluid by counteracting inflammatory pathways. The aim of the injections is to manage the inflammation with a 30-60% chance of improvement in the vision. A steroid implant is an effective way to deliver steroid inside the eye by injecting an implant which can last in the eye by releasing a small amount of steroid slowly over a period of 4-6 months for up to 3 years.
The risks for intravitreal injections include 1:3000 chance of severe visual loss, seeing floaters for a few days, mild redness, grittiness and discomfort. Steroid injections also carry of risk for development of a cataract and infrequently a rise in intraocular or eye pressure which can usually be managed with eyedrops.
Our Consultants at VISIO Health have the expertise in treating uveitis and will help you decide in which treatment option is best for you.
Triamcinolone or Intracinol eye injections | £750 |
Ozurdex eye injection | £2,800 |
Regular eye exams help in early detection and treatment of eye conditions, preventing serious complications and maintaining optimal vision health. They can also detect underlying health issues like diabetes and hypertension.
Copyright 2025 © Eyes RS Limited. All Rights Reserved. Terms of Service | Privacy Policy